Evidence map›Paper›PMID 39505991›Full record

ArticleScientific reports2024

Automatic delineation of cervical cancer target volumes in small samples based on multi-decoder and semi-supervised learning and clinical application.

Haibo Peng, Tao Liu, Pengcheng Li, Fang Yang, Xing Luo, Xiaoqing Sun, Dong Gao, Fengyu Lin, Lecheng Jia, Ningyue Xu and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. HAR-Net: Automatic delineation of clinical target volumes for cervical cancer guided by hierarchical anatomical refinement.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Haibo Peng *Oncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Tao Liu *Oncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Pengcheng LiOncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Fang YangOncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Xing LuoOncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Xiaoqing SunRadiotherapy Laboratory, Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, 518048, China.
Dong GaoUnited Imaging Central Research Institute Co., Ltd, Shanghai, 201807, China.
Fengyu LinRadiotherapy Laboratory, Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, 518048, China.
Lecheng JiaRadiotherapy Laboratory, Shenzhen United Imaging Research Institute of Innovative Medical Equipment, Shenzhen, 518048, China.
Ningyue XuOncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Huigang TanOncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China.
Xi WangDepartment of Ultrasound, The General Hospital of Western Theater Command, Chengdu, 610083, China. wangxcd@163.com.
Tao RenOncology Department, Clinical Medical College, The First Affiliated Hospital of Chengdu Medical College, Chengdu, 610500, China. rentao509@cmc.edu.cn.

Funding

Chengdu Medical Research Project Funding No.2023566Clinical Research Special Program on Science and Technology Project of Sichuan Provincial Health Commission No.23LCYJ049Wu Jieping Medical Funding No.320.6750.2021-22-17
6 · The paper itself

Abstract

Radiotherapy has been demonstrated to be one of the most significant treatments for cervical cancer, during which accurate and efficient delineation of target volumes is critical. To alleviate the data demand of deep learning and promote the establishment and promotion of auto-segmentation models in small and medium-sized oncology departments and single centres, we proposed an auto-segmentation algorithm to determine the cervical cancer target volume in small samples based on multi-decoder and semi-supervised learning (MDSSL), and we evaluated the accuracy via an independent test cohort. In this study, we retrospectively collected computed tomography (CT) datasets from 71 pelvic cervical cancer patients, and a 3:4 ratio was used for the training and testing sets. The clinical target volumes (CTVs) of the primary tumour area (CTV1) and pelvic lymph drainage area (CTV2) were delineated. For definitive radiotherapy (dRT), the primary gross target volume (GTVp) was simultaneously delineated. According to the data characteristics for small samples, the MDSSL network structure based on 3D U-Net was established to train the model by combining clinical anatomical information, which was compared with other segmentation methods, including supervised learning (SL) and transfer learning (TL). The dice similarity coefficient (DSC), 95% Hausdorff distance (HD95) and average surface distance (ASD) were used to evaluate the segmentation performance. The ability of the segmentation algorithm to improve the efficiency of online adaptive radiation therapy (ART) was assessed via geometric indicators and a subjective evaluation of radiation oncologists (ROs) in prospective clinical applications. Compared with the SL model and TL model, the proposed MDSSL model displayed the best DSC, HD95 and ASD overall, especially for the GTVp of dRT. We calculated the above geometric indicators in the range of the ground truth (head-foot direction). In the test set, the DSC, HD95 and ASD of the MDSSL model were 0.80/5.85 mm/0.95 mm for CTV1 of post-operative radiotherapy (pRT), 0.84/ 4.88 mm/0.73 mm for CTV2 of pRT, 0.84/6.58 mm/0.89 mm for GTVp of dRT, 0.85/5.36 mm/1.35 mm for CTV1 of dRT, and 0.84/4.09 mm/0.73 mm for CTV2 of dRT, respectively. In a prospective clinical study of online ART, the target volume modification time (MTime) was 3-5 min for dRT and 2-4 min for pRT, and the main duration of CTV1 modification was approximately 2 min. The introduction of the MDSSL method successfully improved the accuracy of auto-segmentation for the cervical cancer target volume in small samples, showed good consistency with RO delineation and satisfied clinical requirements. In this prospective online ART study, the application of the segmentation model was demonstrated to be useful for reducing the target volume delineation time and improving the efficiency of the online ART workflow, which can contribute to the development and promotion of cervical cancer online ART.

Indexed as

Supervised Machine LearningUterine Cervical NeoplasmsAdultAgedAlgorithmsDeep LearningFemaleHumansMiddle AgedRadiotherapy Planning, Computer-AssistedRetrospective StudiesTomography, X-Ray ComputedAuto-segmentationCervical cancerMulti-decoder semi-supervised learningOnline adaptive radiation therapySmall samples

Identifiers

PMID39505991
PMCPMC11542092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.